BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33652403)

  • 21. Health Technology Assessment and Health Care Reimbursement in the European Union: Permissive Dissensus and the Limits of Harmonization through the Backdoor.
    Löblová O
    J Health Polit Policy Law; 2021 Feb; 46(1):117-145. PubMed ID: 33085959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EMERGENCE OF "DRIVERS" FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT.
    Castro Jaramillo HE; Moreno-Mattar O; Osorio-Cuevas D
    Int J Technol Assess Health Care; 2016 Jan; 32(4):300-306. PubMed ID: 27691993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novelties of the regulation on health technology assessment, a key achievement for the European union health policies.
    Pisapia A; Banfi G; Tomaiuolo R
    Clin Chem Lab Med; 2022 Jul; 60(8):1160-1163. PubMed ID: 35624072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health technology assessment in Saudi Arabia.
    Al-Aqeel S
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):393-402. PubMed ID: 29733227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction initiatives between regulatory, health technology assessment and coverage bodies, and industry.
    Frønsdal K; Pichler F; Mardhani-Bayne L; Henshall C; Røttingen JA; Mørland B; Klemp M
    Int J Technol Assess Health Care; 2012 Oct; 28(4):374-81. PubMed ID: 23062516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE.
    Kani C; Kourafalos V; Litsa P
    Int J Technol Assess Health Care; 2017 Jan; 33(3):396-401. PubMed ID: 28756795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences.
    Augustovski F; Alcaraz A; Caporale J; García Martí S; Pichon Riviere A
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):9-12. PubMed ID: 25420744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden.
    Shah SM; Barron A; Klinger C; Wright JS
    Health Policy; 2014 May; 116(1):27-36. PubMed ID: 24655685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health technology assessment and priority setting for health policy in Sweden.
    Carlsson P
    Int J Technol Assess Health Care; 2004; 20(1):44-54. PubMed ID: 15176176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
    Vreman RA; Mantel-Teeuwisse AK; Hövels AM; Leufkens HGM; Goettsch WG
    Value Health; 2020 Jan; 23(1):10-16. PubMed ID: 31952664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of health technology assessment.
    Banta D
    Health Policy; 2003 Feb; 63(2):121-32. PubMed ID: 12543525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'HTA for Crisis': sharing experiences during the 7th EBHC Symposium.
    Wladysiuk M; Tabor A; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):47-9. PubMed ID: 23402445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applying rapid 'de-facto' HTA in resource-limited settings: experience from Romania.
    Lopert R; Ruiz F; Chalkidou K
    Health Policy; 2013 Oct; 112(3):202-8. PubMed ID: 23953877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EUnetHTA's contribution to the new legal framework for health technology assessment cooperation in Europe.
    Imaz-Iglesia I; Wild C
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e50. PubMed ID: 35652661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEALTH TECHNOLOGY ASSESSMENT IN CENTRAL, EASTERN, AND SOUTH EUROPEAN COUNTRIES: CROATIA.
    Huic M; Tandara Hacek R; Svajger I
    Int J Technol Assess Health Care; 2017 Jan; 33(3):376-383. PubMed ID: 28803589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTA Implementation Roadmap in Central and Eastern European Countries.
    Kaló Z; Gheorghe A; Huic M; Csanádi M; Kristensen FB
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):179-92. PubMed ID: 26763688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union.
    Beletsi A; Koutrafouri V; Karampli E; Pavi E
    Value Health Reg Issues; 2018 Sep; 16():81-91. PubMed ID: 30316029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HEALTH TECHNOLOGY ASSESSMENT IN SERBIA.
    Atanasijevic D; Zah V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):384-389. PubMed ID: 28662733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.